Edition:
United Kingdom

Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

2.49USD
25 Mar 2019
Change (% chg)

-- (--)
Prev Close
$2.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
23,270
52-wk High
$6.35
52-wk Low
$1.96

About

Cidara Therapeutics Inc., is a clinical-stage biotechnology company focused on developing new anti-infectives. The Company’s lead product candidate is rezafungin acetate, which is a molecule in the echinocandin class of antifungals for the treatment and prevention of serious invasive fungal infections, including candidemia and... (more)

Overall

Beta: --
Market Cap(Mil.): $123.10
Shares Outstanding(Mil.): 16.86
Dividend: --
Yield (%): --

Financials

  CDTX.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -3.55 -- --
ROI: -72.93 8.89 13.82
ROE: -77.58 10.02 15.24

Earnings vs. Estimates